[1]
|
Baman, J.R. and Passman, R.S. (2021) Atrial Fibrillation. JAMA, 325, 2218. https://doi.org/10.1001/jama.2020.23700
|
[2]
|
Gelfman, D.M. (2022) Appropriately Targeting Treatment of Atrial Fibrillation to Maximize Benefits in Older Adults. The American Journal of Medicine, 135, 3-4. https://doi.org/10.1016/j.amjmed.2021.06.046
|
[3]
|
Rutherford, O.W., Jonasson, C., Ghanima, W., et al. (2022) Effectiveness and Safety of Oral Anticoagulants in Elderly Patients with Atrial Fibrillation. Heart, 108, 345-352. https://doi.org/10.1136/heartjnl-2020-318753
|
[4]
|
Wijesurendra, R.S. and Casadei, B. (2019) Mechanisms of Atri-al Fibrillation. Heart, 105, 1860-1867.
https://doi.org/10.1136/heartjnl-2018-314267
|
[5]
|
Nojima, T. and Proudfoot, N.J. (2022) Mechanisms of lncRNA Biogenesis as Revealed by Nascent Transcriptomics. Nature Reviews Molecular Cell Biology, 23, 389-406. https://doi.org/10.1038/s41580-021-00447-6
|
[6]
|
Bridges, M.C., Daulagala, A.C. and Kourtidis, A. (2021) LNCcation: lncRNA Localization and Function. Journal of Cell Biology, 220, e202009045. https://doi.org/10.1083/jcb.202009045
|
[7]
|
Wang, W., Tian, B., Ning, Z., et al. (2022) Research Progress of LncRNAs in Atrial Fibrillation. Molecular Biotechnology, 64, 758-772. https://doi.org/10.1007/s12033-022-00449-5
|
[8]
|
Xie, J. (2023) Long Noncoding RNA XIST Regulates Myocar-dial Infarction via miR-486-5p/SIRT1 Axis. Applied Biochemistry and Biotechnology, 195, 725-734. https://doi.org/10.1007/s12010-022-04165-3
|
[9]
|
Zhu, M., Tan, M., Xu, F., et al. (2022) Long Non-Coding RNA XIST Negatively Regulates Thoracic Aortic Aneurysm Cell Proliferation by Targeting the miR-193a-5p/KLF7 Axis. Cellular and Molecular Biology (Noisy-le-grand), 68, 188-193. https://doi.org/10.14715/cmb/2022.68.7.31
|
[10]
|
Yang, K., Xue, Y. and Gao, X. (2021) LncRNA XIST Promotes Atherosclerosis by Regulating miR-599/TLR4 Axis. Inflammation, 44, 965-973. https://doi.org/10.1007/s10753-020-01391-x
|
[11]
|
Hindricks, G., Potpara, T., Dagres, N., et al. (2021) 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Asso-ciation for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 42, 373-498. https://doi.org/10.1093/eurheartj/ehaa612
|
[12]
|
Tiver, K.D., Quah, J., et al. (2021) Atrial Fibrillation Burden: An Update—The Need for a CHA2DS2-VASc-AF Burden Score. Europace, 23, 665-673. https://doi.org/10.1093/europace/euaa287
|
[13]
|
Lozano-Velasco, E., Franco, D., Aranega, A., et al. (2020) Genetics and Epigenetics of Atrial Fibrillation. International Journal of Molecular Sciences, 21, 5717. https://doi.org/10.3390/ijms21165717
|
[14]
|
Liu, Y., Liang, X., Wang, J., et al. (2021) Identification of Atrial Fibril-lation-Associated lncRNAs and Exploration of Their Functions Based on WGCNA and ceRNA Network Analyses. General Physiology and Biophysics, 40, 289-305.
https://doi.org/10.4149/gpb_2021015
|
[15]
|
Fang, Y., Xu, Y., Wang, R., et al. (2020) Recent Advances on the Roles of LncRNAs in Cardiovascular Disease. Journal of Cellular and Molecular Medicine, 24, 12246-12257. https://doi.org/10.1111/jcmm.15880
|
[16]
|
Du, J., Li, Z., Wang, X., et al. (2020) Long Noncoding RNA TCONS-00106987 Promotes Atrial Electrical Remodelling during Atrial Fibrillation by Sponging miR-26 to Regulate KCNJ2. Journal of Cellular and Molecular Medicine, 24, 12777-12788. https://doi.org/10.1111/jcmm.15869
|
[17]
|
Li, J., Zhang, Q. and Jiao, H. (2021) LncRNA NRON Promotes M2 Macrophage Polarization and Alleviates Atrial Fibrosis through Suppressing Exosomal miR-23a Derived from Atrial Myocytes. Journal of the Formosan Medical Association, 120, 1512-1519. https://doi.org/10.1016/j.jfma.2020.11.004
|
[18]
|
Chen, X., He, X.Y., Dan, Q., et al. (2022) FAM201A, a Long Noncoding RNA Potentially Associated with Atrial Fibrillation Identified by ceRNA Network Analyses and WGCNA. BMC Medical Genomics, 15, Article No. 80.
https://doi.org/10.1186/s12920-022-01232-w
|
[19]
|
Shi, J., Chen, L., Chen, S., et al. (2021) Circulating Long Noncoding RNA, GAS5, as a Novel Biomarker for Patients with Atrial Fibrillation. Journal of Clinical Laboratory Analysis, 35, e23572. https://doi.org/10.1002/jcla.23572
|
[20]
|
Loda, A. and Heard, E. (2019) Xist RNA in Action: Past, Present, and Future. PLOS Genetics, 15, e1008333.
https://doi.org/10.1371/journal.pgen.1008333
|
[21]
|
Wen, J.L., Ruan, Z.B., Wang, F., et al. (2023) Construction of Atrial Fibrillation-Related circRNA/lncRNA-miRNA- mRNA Regulatory Network and Analysis of Potential Biomarkers. Journal of Clinical Laboratory Analysis, 37, e24833.
https://doi.org/10.1002/jcla.24833
|
[22]
|
Dai, W., Chao, X., Jiang, Z., et al. (2021) lncRNA KCNQ1OT1 May Function as a Competitive Endogenous RNA in Atrial Fibrillation by Sponging miR-223-3p. Molecular Medicine Re-ports, 24, 870.
https://doi.org/10.3892/mmr.2021.12510
|
[23]
|
Yao, L., Zhou, B., You, L., et al. (2020) LncRNA MIAT/miR-133a-3p Axis Regulates Atrial Fibrillation and Atrial Fibrillation-Induced Myocardial Fibrosis. Molecular Biology Reports, 47, 2605-2617.
https://doi.org/10.1007/s11033-020-05347-0
|
[24]
|
Zhao, Z., Liu, G., Zhang, H., et al. (2021) BIRC5, GAJ5, and lncRNA NPHP3-AS1 Are Correlated with the Development of Atrial Fibrillation-Valvular Heart Disease. International Heart Journal, 62, 153-161.
https://doi.org/10.1536/ihj.20-238
|
[25]
|
Reddy, Y.N.V., Borlaug, B.A. and Gersh, B.J. (2022) Management of Atrial Fibrillation across the Spectrum of Heart Failure with Preserved and Reduced Ejection Fraction. Circulation, 146, 339-357.
https://doi.org/10.1161/CIRCULATIONAHA.122.057444
|
[26]
|
Menichelli, D., Sciacqua, A., Cangemi, R., et al. (2021) Atrial Fibrillation Pattern, Left Atrial Diameter and Risk of Cardiovascular Events and Mortality. A Prospective Multicenter Cohort Study. International Journal of Clinical Practice, 75, e13771. https://doi.org/10.1111/ijcp.13771
|
[27]
|
Zhang, M.J., Yan, Z., Qin, J., et al. (2022) XIST as a Valuable Biomarker for Prognosis and Clinical Parameters in Diverse Tumors: A Comprehensive Meta- and Bioinformatics Analysis. Neo-plasma, 69, 1217-1227.
https://doi.org/10.4149/neo_2022_220329N352
|
[28]
|
Li, Y., Yuan, X., Shi, Z., et al. (2021) LncRNA XIST Serves as a Diagnostic Biomarker in Gestational Diabetes Mellitus and Its Regulatory Effect on Trophoblast Cell via miR-497-5p/FOXO1 Axis. Cardiovascular Diagnosis and Therapy, 11, 716-725. https://doi.org/10.21037/cdt-21-110
|
[29]
|
Lan, F., Zhang, X., Li, H., et al. (2021) Serum Exosomal lncRNA XIST Is a Potential Non-Invasive Biomarker to Diagnose Recurrence of Triple-Negative Breast Cancer. Journal of Cellular and Molecular Medicine, 25, 7602-7607.
https://doi.org/10.1111/jcmm.16009
|
[30]
|
Zheng, P.F., Chen, L.Z., Liu, P., et al. (2022) A Novel lncRNA-miRNA-mRNA Triple Network Identifies lncRNA XIST as a Biomarker for Acute Myocardial Infarction. Ag-ing (Albany NY), 14, 4085-4106.
https://doi.org/10.18632/aging.204075
|
[31]
|
Fan, S. and Hu, Y. (2022) Integrative Analyses of Biomarkers and Pathways for Heart Failure. BMC Medical Genomics, 15, Article No. 72. https://doi.org/10.1186/s12920-022-01221-z
|